Chapter 49 Zhang Yang, I want to make progress so much!


Chapter 49 Zhang Yang, I want to make progress so much!

"Dean Zhou, welcome, please take a seat."

Dean Zhou's full name is Zhou Yongren. He has just turned fifty and is in the prime of life.

He immediately sat down and said:

"Mr. Zhang, I don't want to be in a circle anymore. The main reason for this visit is to reach an agreement with you. I hope that your company can bring all the benefits to you in the future. Clinical trials of new drugs are placed in our hospital, especially drugs for treating blood diseases. "

Zhang Yang was stunned for a moment, a little surprised.

When pharmaceutical companies are preparing to conduct clinical trials of innovative drugs, they can indeed independently select suitable hospitals to conduct clinical trials. However, for this matter, Dr. Zhou personally comes to visit?

"Dean Zhou, we cooperate very well. Even if you don't say it, we will definitely have more cooperation opportunities in the future..."

Before he finished speaking, Dean Zhou laughed. He waved his hands:

“I know, but I just want to hear your personal promise, otherwise I won’t be able to let go.”

After saying that, he paused for a moment and continued:

"I'll make it clear."

"You may not know it well. In fact, every year, all our top tertiary hospitals across the country hold a national meeting. Not only the hospital, but also each department is ranked nationally every year. "

"The Department of Hematology is the star department of our Third People's Hospital, ranking 21st in the country last year!"
>
“I want to go one step further!”

"Go further?"

Zhang Yang was puzzled. Upon seeing this, Dean Zhou continued:

"I won't say more about how the hospital was selected. After all, judging from the overall strength of the hospital, Our Third People’s Hospital is indeed far behind.”

“But the department rankings are still there. The most important things are "medical record data" and "scientific research capabilities"! ”

“Simply put, medical record data is the patient base. The more patient cases we treat every year, the more it can prove that we have strong business capabilities and the number of severe cases we treat. The more patients there are, the more proof the medical level is! ”

"Scientific research capabilities mainly include academic papers and scientific research projects. For example, Director Hu from our Department of Hematology published two papers last month on the clinical application of 'Qingshan Avatrombopag Tablets' in blood diseases, which directly fills the domestic market. The gap in the clinical application of 'Avatrombopag Tablets' has provided valuable clinical data for all doctors in the country, and also added a lot of points to our department!"

"Of course..."

He looked at Zhang Yang:

“Of course all this is because you put the clinical trial in our hospital, so we can attract so many patients and have so much clinical data!”< br>
"So...this time after I saw your company's clinical phase III data of 'ITG human genitin', I had to come and visit you in person as soon as possible."

"Zhang Yang, I want to make progress so much."

Zhang Yang revealed that Dean Zhou had taken a fancy to Qingshan Pharmaceutical's strong research and development capabilities in blood diseases and established a good relationship in advance.

But this is also human nature.

It is conceivable that once "ITG Human Myelopoietin" can continue to complete the Phase III trial with the current therapeutic effect,

how many patients with "aplastic anemia" will come here to visit it? !

You know, this is completely different from "Avatrombopag". This is a drug that can completely cure aplastic anemia!

Once patients flock here, there is no doubt that the Hematology Department of Chengdu Third People’s Hospital will reach a higher level!

"Of course Mr. Zhang, I won't let you make your promise in vain."

"As long as you are willing to agree to a cooperative relationship with us, all new drugs will be put into a trial site in our hospital. I can guarantee that no matter which department, I will demand full cooperation."

"In addition, as soon as your 'ITG myelopoietin' is put on the market, we will purchase it immediately, and the first purchase volume will not be low. At 20 million yuan!”

Hearing this, Zhang Yang already had a plan in mind.

It can be seen that Dean Zhou is very concerned about this matter. He is not opposed to it. After all, he is familiar with Feng Gang and Director Hu of the Third People's Hospital. "Yuan Zhou, there is no problem with this. I also look forward to our continued cooperation."

"Okay, okay, okay!"

Dean Zhou didn't Wanting to show off so readily, he agreed, with a smile on his face.

At this moment, Zhang Yang suddenly thought of the "Icofenprovir" he had just obtained, and said casually:

"We happen to be developing a drug to treat liver disease, and it will be available in clinical trials by then. I'm going to trouble you."

"No problem! It's a small matter!"

After talking about the business, the two chatted for a while, and Dean Zhou left with satisfaction.

Zhang Yang thought for a while, and then gradually realized the great significance of a top-notch first-line drug to the hospital.

Now that information is so developed, almost all good medical resources and doctor resources are concentrated in the top few hospitals. It is really difficult for hospitals at the bottom of the ranking to make breakthroughs and break the balance!

And now,

Whether it is "Qingshan Avatrombopag Tablets" or "ITG Human Myelopoietin", these hospitals have been given a chance to make a breakthrough.

At least there is a little hope, isn't there?

……

After Dean Zhou left, Zhang Yang immediately focused again on the "ITG Human Myelopoietin" clinical trial.

One month later,

the first batch of 75 patients participating in the "ITG" clinical trial completed three months of treatment. Next,

they only The final blood draw and bone puncture examination need to be completed to officially end the Phase III clinical trial.

Rongcheng Third People's Hospital, Clinical Trial Center.

"No. 21, Xia Qiang."

"Yes, I am."

"This is your checklist. After drawing the blood, do a bone marrow puncture, and then rest in the ward24 I won’t leave until a few hours later. By the way, this time I will leave my bones I’ll inform you of the results of the marrow puncture, so that you don’t have to go for another check-up.”

“Okay, thank you.” Walk to the blood drawing office of the clinical trial center.

Bone marrow puncture is the gold standard for clinical judgment of "aplastic anemia".

As we all know, aplastic anemia is caused by a problem with one's own bone marrow cells. As long as the bone marrow cell proliferation is found to return to normal through a needle biopsy, it means that the aplastic anemia has been completely cured.

"Next, Zhou Xiaomei."

Xia Qiang and Zhou Xiaomei passed each other and came to the blood drawing room with the list in hand.

At this time, there was a long queue outside the blood drawing room. While waiting, everyone couldn't help but discuss:

"I'm a little excited. Do you feel better? I think I must have been selected into the 'experimental group', definitely not the control group. I can clearly feel that my condition has been much better in the past three months."

"Haha , I hope so. I feel that I should have been selected into the experimental group. I secretly tell you that yesterday I went to take blood in advance and the blood test result was completely normal. I may be cured by the way! Sister Xiaoduo, how do you feel? ?”
"I also think it feels good, but this double-blind test is really worrying, especially since the control group was also taking 'Avatrombopag', so it's hard to tell which group you are in. By the way, Li Bing, you How do you feel? "

"I...? I feel fine, there is no obvious change. From what you said, I think I may have been in the 'control group'..."
< br>(End of this chapter)